Pneumococcal vaccination in celiac disease

Antonio Carroccio, Pasquale Mansueto, Vincenzo Villanacci, Antonio Carroccio, Giovanni Casella, Fabio Ingravalle, Claudio Monti, Giorgio Abbate, Fulvio Bonetti, Fabio Ingravalle, Gabrio Bassotti

Risultato della ricerca: Article

Abstract

Introduction: Celiac disease (CD) is an immune-mediated disorder associated with gluten exposure ingenetically predisposed subjects.Areas covered: Infectious disease is one of the causes of morbidity and mortality in CD patients.Invasive streptococcus pneumoniae (pneumococcus) is a particularly dangerous morbid condition inboth the general population and celiac patients. Pneumococcal vaccination is the most effective meansfor its prevention.Expert opinion: In CD, evaluation of spleen function should be useful to select patients who maybenefit from vaccination to reduce the risk of pneumococcal disease. Different strategies could beemployed: physicians could search for signs of hyposplenism on peripheral blood smear or abdominalultrasound. However, the best strategy to identify which patients will benefit from pneumococcalvaccination has not yet been defined.
Lingua originaleEnglish
Numero di pagine6
RivistaEXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
Stato di pubblicazionePublished - 2019

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cita questo

Carroccio, A., Mansueto, P., Villanacci, V., Carroccio, A., Casella, G., Ingravalle, F., Monti, C., Abbate, G., Bonetti, F., Ingravalle, F., & Bassotti, G. (2019). Pneumococcal vaccination in celiac disease. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY.